• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于蛋白质修饰的功能化半遥爪聚[N-(2-羟丙基)甲基丙烯酰胺]

Functionalized semitelechelic poly[N-(2-hydroxypropyl)methacrylamide] for protein modification.

作者信息

Lu Z R, Kopecková P, Wu Z, Kopecek J

机构信息

Departments of Pharmaceutics and Pharmaceutical Chemistry/CCCD and of Bioengineering, Mass Spectrometry Facility, University of Utah, Salt Lake City, Utah 84112, USA.

出版信息

Bioconjug Chem. 1998 Nov-Dec;9(6):793-804. doi: 10.1021/bc980058r.

DOI:10.1021/bc980058r
PMID:9815174
Abstract

Semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]s (ST-PHPMA) with different functional end groups, namely carboxyl, methyl ester, hydrazide, and amino groups, were prepared by chain transfer free-radical polymerization. 2,2'-Azobisisobutyronitrile (AIBN) was used as an initiator and 3-mercaptopropionic acid, methyl 3-mercaptopropionate, 3-mercaptopropionic hydrazide, and 2-mercaptoethylamine were used as chain-transfer agents. The semitelechelic polymers have been characterized by end-group analysis, size-exclusion chromatography (SEC), and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). The effects of the concentrations of the mercaptans and the initiator on the molecular weight of the polymers have been investigated. The higher the concentration of mercaptan, the lower the molecular weight of ST-PHPMA. The concentration of initiator did not have a significant effect on the molecular weight of the semitelechelic polymers. The end groups of the ST polymers can be readily transformed by polymeranalogous reactions. A model protein, alpha-chymotrypsin, has been modified with ST-PHPMA-CONHNH2 and ST-PHPMA-COOSu and the conjugates characterized by MALDI-TOF MS. The activity of modified chymotrypsins toward a high molecular weight substrate, P-Gly-Leu-Phe-NAp (where P is the HPMA copolymer backbone, and NAp is p-nitroanilide), was slightly lower than the activity of the native enzyme. The cleavage of a low molecular weight substrate, Z-Gly-Leu-Phe-NAp, by modified chymotrypsins was dependent on their structure. Whereas the activity of the amino group modified chymotrypsins was higher than that of the native enzyme, the activity of carboxyl-modified chymotrypsins was lower than that of the native enzyme. In summary, the data seem to indicate that ST-PHPMA is an effective protein-modifying agent.

摘要

通过链转移自由基聚合制备了具有不同官能端基(即羧基、甲酯基、酰肼基和氨基)的半遥爪聚[N-(2-羟丙基)甲基丙烯酰胺](ST-PHPMA)。使用2,2'-偶氮二异丁腈(AIBN)作为引发剂,3-巯基丙酸、3-巯基丙酸甲酯、3-巯基丙酸酰肼和2-巯基乙胺作为链转移剂。通过端基分析、尺寸排阻色谱(SEC)和基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF MS)对这些半遥爪聚合物进行了表征。研究了硫醇和引发剂浓度对聚合物分子量的影响。硫醇浓度越高,ST-PHPMA的分子量越低。引发剂浓度对半遥爪聚合物的分子量没有显著影响。ST聚合物的端基可以通过聚合物类似反应轻松转化。一种模型蛋白α-胰凝乳蛋白酶已用ST-PHPMA-CONHNH2和ST-PHPMA-COOSu进行了修饰,并通过MALDI-TOF MS对缀合物进行了表征。修饰后的胰凝乳蛋白酶对高分子量底物P-Gly-Leu-Phe-NAp(其中P是HPMA共聚物主链,NAp是对硝基苯胺)的活性略低于天然酶的活性。修饰后的胰凝乳蛋白酶对低分子量底物Z-Gly-Leu-Phe-NAp的切割取决于它们的结构。氨基修饰的胰凝乳蛋白酶的活性高于天然酶,而羧基修饰的胰凝乳蛋白酶的活性低于天然酶。总之,数据似乎表明ST-PHPMA是一种有效的蛋白质修饰剂。

相似文献

1
Functionalized semitelechelic poly[N-(2-hydroxypropyl)methacrylamide] for protein modification.用于蛋白质修饰的功能化半遥爪聚[N-(2-羟丙基)甲基丙烯酰胺]
Bioconjug Chem. 1998 Nov-Dec;9(6):793-804. doi: 10.1021/bc980058r.
2
Branched polymer-protein conjugates made from mid-chain-functional P(HPMA).支化聚合物-蛋白质偶联物由中链功能化 P(HPMA)制成。
Biomacromolecules. 2009 Oct 12;10(10):2847-51. doi: 10.1021/bm900678r.
3
Coating of DNA/poly(L-lysine) complexes by covalent attachment of poly[N-(2-hydroxypropyl)methacrylamide].通过聚[N-(2-羟丙基)甲基丙烯酰胺的共价连接对DNA/聚(L-赖氨酸)复合物进行包被。
Biomacromolecules. 2006 Jan;7(1):122-30. doi: 10.1021/bm050524x.
4
Structural characterization of synthetic poly(ester amide) from sebacic acid and 4-amino-1-butanol by matrix-assisted laser desorption ionization time-of-flight/time-of-flight tandem mass spectrometry.通过基质辅助激光解吸电离飞行时间/飞行时间串联质谱法对由癸二酸和4-氨基-1-丁醇合成的聚(酯酰胺)进行结构表征。
Rapid Commun Mass Spectrom. 2008;22(6):739-54. doi: 10.1002/rcm.3417.
5
Well-defined protein-polymer conjugates via in situ RAFT polymerization.通过原位可逆加成-断裂链转移(RAFT)聚合制备的结构明确的蛋白质-聚合物共轭物。
J Am Chem Soc. 2007 Jun 6;129(22):7145-54. doi: 10.1021/ja070956a. Epub 2007 May 15.
6
Native protein-initiated ATRP: a viable and potentially superior alternative to PEGylation for stabilizing biologics.天然蛋白质引发的原子转移自由基聚合反应:一种用于稳定生物制品的可行且可能更优的聚乙二醇化替代方法。
Acta Biomater. 2009 Feb;5(2):560-9. doi: 10.1016/j.actbio.2008.08.010. Epub 2008 Aug 31.
7
Interpretation of reversible addition-fragmentation chain-transfer polymerization mechanism by MALDI-TOF-MS.通过基质辅助激光解吸电离飞行时间质谱法对可逆加成-断裂链转移聚合机理的解析
Anal Chem. 2007 Apr 1;79(7):2722-7. doi: 10.1021/ac061930p. Epub 2007 Feb 22.
8
Matrix-assisted and polymer-assisted laser desorption/ionization time-of-flight mass spectrometric analysis of low molecular weight polystyrenes and polyethylene glycols.低分子量聚苯乙烯和聚乙二醇的基质辅助及聚合物辅助激光解吸/电离飞行时间质谱分析
Rapid Commun Mass Spectrom. 2004;18(23):2904-12. doi: 10.1002/rcm.1707.
9
Matrix-assisted laser desorption/ionization time-of-flight/time-of-flight tandem mass spectra of poly(butylene adipate).聚己二酸丁二醇酯的基质辅助激光解吸/电离飞行时间/飞行时间串联质谱
Rapid Commun Mass Spectrom. 2006;20(11):1683-94. doi: 10.1002/rcm.2483.
10
Molecular mass determination of plasma-derived glycoproteins by ultraviolet matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with internal calibration.采用内标法通过紫外基质辅助激光解吸/电离飞行时间质谱法测定血浆来源糖蛋白的分子量。
J Mass Spectrom. 2002 Nov;37(11):1118-30. doi: 10.1002/jms.372.

引用本文的文献

1
Polymer nanomedicines.聚合物纳米药物。
Adv Drug Deliv Rev. 2020;156:40-64. doi: 10.1016/j.addr.2020.07.020. Epub 2020 Jul 28.
2
Macromolecular therapeutics.大分子疗法
J Control Release. 2014 Sep 28;190:288-303. doi: 10.1016/j.jconrel.2014.04.013. Epub 2014 Apr 18.
3
Polymer-drug conjugates: origins, progress to date and future directions.聚合物-药物偶联物:起源、至今的进展和未来方向。
Adv Drug Deliv Rev. 2013 Jan;65(1):49-59. doi: 10.1016/j.addr.2012.10.014. Epub 2012 Nov 2.
4
HPMA copolymers: origins, early developments, present, and future.HPMA 共聚物:起源、早期发展、现状和未来。
Adv Drug Deliv Rev. 2010 Feb 17;62(2):122-49. doi: 10.1016/j.addr.2009.10.004. Epub 2009 Nov 14.
5
Beyond oncology--application of HPMA copolymers in non-cancerous diseases.超越肿瘤学——HPMA 共聚物在非癌症疾病中的应用。
Adv Drug Deliv Rev. 2010 Feb 17;62(2):258-71. doi: 10.1016/j.addr.2009.10.006. Epub 2009 Nov 10.
6
Tumor-targeted HPMA copolymer-(RGDfK)-(CHX-A''-DTPA) conjugates show increased kidney accumulation.肿瘤靶向性的聚(N-(2-羟丙基)甲基丙烯酰胺)共聚物-(RGDfK)-(环己二胺四乙酸)缀合物显示出肾脏蓄积增加。
J Control Release. 2008 Dec 18;132(3):193-9. doi: 10.1016/j.jconrel.2008.07.014. Epub 2008 Jul 18.
7
Semitelechelic HPMA copolymers functionalized with triphenylphosphonium as drug carriers for membrane transduction and mitochondrial localization.用三苯基膦功能化的半遥爪型HPMA共聚物作为用于膜转导和线粒体定位的药物载体。
Biomacromolecules. 2006 Aug;7(8):2347-56. doi: 10.1021/bm060336m.
8
Degradation and aggregation of human calcitonin in vitro.人降钙素在体外的降解与聚集
Pharm Res. 1999 Mar;16(3):359-67. doi: 10.1023/a:1018813416523.